Literature DB >> 23145933

The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells.

Ruurd Torensma1, Henk-Jan Prins, Ellen Schrama, Eugène T P Verwiel, Anton C M Martens, Helene Roelofs, Bastiaan J H Jansen.   

Abstract

Bone marrow (BM) stromal cells (MSCs), also known as mesenchymal stem cells, display a high degree of heterogeneity. To shed light on the causes of this heterogeneity, MSCs were collected from either human BM (n=5) or adipose tissue (AT) (n=5), and expanded using 2 different culture methods: one based on fetal calf serum, and one based on human platelet lysate. After initial expansion, MSCs were frozen, and the vials were transported to 3 different laboratories and grown for 1 passage using the same brand of culture plastic, medium, and supplements. Subsequently, the cells were harvested and assayed for their gene expression profile using the Affymetrix exon microarray platform. Based on gene expression profiles, the most discriminative feature was the anatomical harvesting site, followed by culture methodology. Remarkably, genes in the WNT pathway were expressed at higher levels in BM-derived MSCs than in AT-derived MSCs. Although differences were found between laboratories, cell culture location only slightly affects heterogeneity. Furthermore, individual donors contributed marginally to the observed differences in transcriptomes. Finally, BM-derived MSCs displayed the highest level of similarity, irrespective their culture conditions, when compared to AT-derived cells.

Mesh:

Year:  2012        PMID: 23145933      PMCID: PMC3608038          DOI: 10.1089/scd.2012.0384

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  70 in total

1.  Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture.

Authors:  Andrew C Boquest; Aboulghassem Shahdadfar; Katrine Frønsdal; Olafur Sigurjonsson; Siv H Tunheim; Philippe Collas; Jan E Brinchmann
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

2.  Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain.

Authors:  Cindy T J van Velthoven; Annemieke Kavelaars; Frank van Bel; Cobi J Heijnen
Journal:  Brain Behav Immun       Date:  2011-04-05       Impact factor: 7.217

3.  Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density.

Authors:  Dominik Cholewa; Thomas Stiehl; Anne Schellenberg; Gudrun Bokermann; Sylvia Joussen; Carmen Koch; Thomas Walenda; Norbert Pallua; Anna Marciniak-Czochra; Christoph V Suschek; Wolfgang Wagner
Journal:  Cell Transplant       Date:  2011-03-07       Impact factor: 4.064

4.  Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function.

Authors:  Heba Abdelrazik; Grazia M Spaggiari; Laura Chiossone; Lorenzo Moretta
Journal:  Eur J Immunol       Date:  2011-10-18       Impact factor: 5.532

5.  A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function.

Authors:  Katsuhide Okunishi; Makoto Dohi; Kazuyuki Nakagome; Ryoichi Tanaka; Shinya Mizuno; Kunio Matsumoto; Jun-Ichi Miyazaki; Toshikazu Nakamura; Kazuhiko Yamamoto
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

6.  Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.

Authors:  I Müller; S Kordowich; C Holzwarth; C Spano; G Isensee; A Staiber; S Viebahn; F Gieseke; H Langer; M P Gawaz; E M Horwitz; P Conte; R Handgretinger; M Dominici
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

7.  Microvascular pericytes express aggrecan message which is regulated by BMP-2.

Authors:  D L Diefenderfer; C T Brighton
Journal:  Biochem Biophys Res Commun       Date:  2000-03-05       Impact factor: 3.575

8.  Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots.

Authors:  J K Fraser; I Wulur; Z Alfonso; M Zhu; E S Wheeler
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

9.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

Authors:  Ralf Hass; Cornelia Kasper; Stefanie Böhm; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2011-05-14       Impact factor: 5.712

10.  High abundance of CD271(+) multipotential stromal cells (MSCs) in intramedullary cavities of long bones.

Authors:  George Cox; Sally A Boxall; Peter V Giannoudis; Conor T Buckley; Tarek Roshdy; Sarah M Churchman; Dennis McGonagle; Elena Jones
Journal:  Bone       Date:  2011-07-23       Impact factor: 4.398

View more
  16 in total

1.  Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.

Authors:  Sara M Melief; Jaap Jan Zwaginga; Willem E Fibbe; Helene Roelofs
Journal:  Stem Cells Transl Med       Date:  2013-05-21       Impact factor: 6.940

Review 2.  Partnership between platelet-rich plasma and mesenchymal stem cells: in vitro experience.

Authors:  Eva Rubio-Azpeitia; Isabel Andia
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

3.  Aldehyde Dehydrogenase Activity in Adipose Tissue: Isolation and Gene Expression Profile of Distinct Sub-population of Mesenchymal Stromal Cells.

Authors:  Mehdi Najar; Emerence Crompot; Leo A van Grunsven; Laurent Dollé; Laurence Lagneaux
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

4.  High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cells.

Authors:  Amel Dudakovic; Emily Camilleri; Scott M Riester; Eric A Lewallen; Sergiy Kvasha; Xiaoyue Chen; Darcie J Radel; Jarett M Anderson; Asha A Nair; Jared M Evans; Aaron J Krych; Jay Smith; David R Deyle; Janet L Stein; Gary S Stein; Hee-Jeong Im; Simon M Cool; Jennifer J Westendorf; Sanjeev Kakar; Allan B Dietz; Andre J van Wijnen
Journal:  J Cell Biochem       Date:  2014-10       Impact factor: 4.429

5.  FGF-2 addition during expansion of human bone marrow-derived stromal cells alters MSC surface marker distribution and chondrogenic differentiation potential.

Authors:  S Hagmann; B Moradi; S Frank; T Dreher; P W Kämmerer; W Richter; T Gotterbarm
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

6.  β-Catenin Accumulation Is Associated With Increased Expression of Nanog Protein and Predicts Maintenance of MSC Self-Renewal.

Authors:  Sang-Jin Yu; Hyun-Je Kim; Eui Seok Lee; Chung-Gyu Park; Su Jin Cho; Soung-Hoo Jeon
Journal:  Cell Transplant       Date:  2016-09-27       Impact factor: 4.064

7.  Age-related effects on the potency of human adipose-derived stem cells: creation and evaluation of superlots and implications for musculoskeletal tissue engineering applications.

Authors:  Josephine C Bodle; Stephanie D Teeter; Brandon H Hluck; Joseph W Hardin; Susan H Bernacki; Elizabeth G Loboa
Journal:  Tissue Eng Part C Methods       Date:  2014-05-01       Impact factor: 3.056

8.  Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction.

Authors:  Mohsen Moslem; Irina Eberle; Iuliia Weber; Reinhard Henschler; Tobias Cantz
Journal:  Stem Cells Int       Date:  2015-06-22       Impact factor: 5.443

9.  Expression of surface markers and myogenic potential of rat bone marrow- and adipose-derived stem cells: a comparative study.

Authors:  Vahid Bayati; Mahmoud Hashemitabar; Roohollah Gazor; Reza Nejatbakhsh; Dariush Bijannejad
Journal:  Anat Cell Biol       Date:  2013-06-30

10.  Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species.

Authors:  J Su; X Chen; Y Huang; W Li; J Li; K Cao; G Cao; L Zhang; F Li; A I Roberts; H Kang; P Yu; G Ren; W Ji; Y Wang; Y Shi
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.